Cash Rich Nestlé Looking For Acquisitions

Swiss food and drink giant Nestlé has agreed to sell its shares in US eyecare firm Alcon to multinational pharmaceutical company Novartis for US$39bn. This massive sale gives the firm cash to spend on acquisitions in the health, nutrition and well-being sectors that are now the firm's stated priorities. This extra finance means that Nestlé is likely to smash its self-imposed US$2bn annual acquisition budget in the coming year; however, where the money will been spent is open to

To read the full article, please choose one of the following options: